UTHSC professor's startup receives federal grants, LaunchTN funds for leukemia therapy

Wei Li is the founder of SEAK Therapeutics, a UTHSC-connected startup that ’s in the early stages of developing a compound called SEAK-114, which is expected to act as a targeted leukemia therapy.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news